Tu Peso Ideal

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• SemaglutideType not stated
• TirzepatideType not stated

What they publish

Tu Peso Ideal publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Semaglutide published from $154/month and tirzepatide from $329/month, both stated to include medication and medical supervision (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Virtual clinic model, published as avoiding travel and waiting rooms, on a single subscription.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• Spanish-language service in a market where almost every GLP-1 provider publishes in English only. That is a genuine access gap.
• All-inclusive pricing covering medication and supervision makes the figure directly comparable.
• The page did not state whether the medication is FDA-approved or compounded — at $154/month it is worth establishing.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Confirm whether the medication is FDA-approved or compounded, and where it is dispensed from.
• Confirm which states or countries the service actually operates in.
• Establish whether the price holds as the dose escalates.